# Letrozole

## Femara 2.5mg

| TAH Drug Code      | [OFEM](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OFEM)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | No Data                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Dosing             | 2.5 mg orally once a day， without regard to meals for a planned duration of 5 years; discontinue at relapse， disease progression or unacceptable toxicity. In patients with advanced disease， treatment with Femara should continue until tumor progression is evident.                                                                                                                                                                                                                                                                                                                                                                                                                |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Contraindications  | Hypersensitivity to letrozole or any component of the formulation; pregnancy. Use in patients <18 years of age; premenopausal endocrine status; breastfeeding.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Adverse Effects    | Headache， nausea， peripheral edema， fatigue， hot flushes. Cardiovascular: Edema (7.2% to 18.4% ) Dermatologic: Hot sweats (5% to 49.7% )， Sweating (up to 24.2% ) Gastrointestinal: Constipation (1.5% to 11.3% )， Diarrhea (5% to 8% )， Loss of appetite (3% to 5% )， Nausea (8.6% to 17% )， Vomiting (2.7% to 7% ) Musculoskeletal: Arthralgia (8% to 22% )， Arthritis (6.7% to 21.1%)， Backache (5% to 18% )， Bone pain (22% )， Myalgia (6.4% to 6.7% ) Neurologic: Asthenia (4% to 33.6% )， Dizziness (2.4% to 14.2% .)， Headache (3.5% to 20.1% )， Insomnia (5.8% to 7% .)， Somnolence (2% to 3% .) Respiratory: Dyspnea (5.5% to 18% ) Other: Fatigue (6% to 13% ) |
| Pregnancy          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Lactation          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| More Info          | [UpToDate](https://www.uptodate.com/contents/letrozole-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |

